Related Experiment Videos
[Ischemic vs nonischemic heart failure--does etiology matter?]
1Departement Innere Medizin, Universitätsspital Zürich. dimscy@usz.unizh.ch
Insights
Understanding the cause of heart failure is crucial. Ischemic heart failure generally has a worse prognosis, though some drug responses differ between ischemic and non-ischemic heart failure.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Trials
Context:
- Prognosis of ischemic heart failure is often worse than non-ischemic heart failure in large trials.
- Therapeutic responses to certain medications vary significantly between these etiologies.
- Identifying the underlying cause of heart failure is essential for effective management.
Purpose:
- To compare the prognosis and therapeutic responses in ischemic versus non-ischemic heart failure.
- To highlight the importance of identifying specific etiologies like hibernating myocardium, hypertensive heart disease, and alcoholic cardiomyopathy.
- To emphasize the need for etiological diagnosis in all heart failure patients.
Summary:
- Large-scale trials indicate a poorer prognosis for ischemic heart failure compared to non-ischemic forms.
- While core medications show similar efficacy, non-ischemic heart failure patients exhibit better responses to amiodarone, amlodipine, digoxin, and growth hormone.
- Recognizing hibernating myocardium is vital for potential improvement via revascularization.
- Specific interventions exist for hypertensive heart disease, alcoholic cardiomyopathy, and tachyarrhythmia-induced LV dysfunction.
Impact:
- Highlights the prognostic differences and differential drug responses in heart failure etiologies.
- Underscores the clinical significance of diagnosing specific causes for targeted treatment strategies.
- Emphasizes the need for etiological investigation to optimize patient outcomes in heart failure management.
Abstract:
In most large scale trials the prognosis of ischemic heart failure is worse than in patients with non-ischemic etiology. The therapeutic effect of essential drugs such as ACE-inhibitors, betablockers and diuretics is similar, but response to some other drugs (amiodarone, amlodipine, digoxin, growth hormone) is better in non-ischemic heart failure. Of great practical importance is the recognition of hibernating myocardium in coronary artery disease, since revascularisation may significantly improve left ventricular function. Specific therapeutic interventions are possible in hypertensive heart disease, alcoholic cardiomyopathy and LV-dysfunction to tachyarrhythmias. The etiology of heart failure should therefore be cleared in all patients.